PRODUCT INTRODUCTION
Evaprin 40mg Injection is a medication primarily composed of Evacetrapib, a cholesteryl ester transfer protein (CETP) inhibitor. It is administered via injection and is indicated for the management of dyslipidemia in patients who are at high risk of cardiovascular events. This medication works by inhibiting the CETP enzyme, which helps increase high-density lipoprotein (HDL) cholesterol levels while reducing low-density lipoprotein (LDL) cholesterol levels, thus aiding in the management of lipid profiles.
USES OF Evaprin 40mg Injection
Evaprin 40mg Injection is prescribed for the following purposes:
- Management of dyslipidemia: Evaprin is utilized to regulate lipid profiles in individuals with dyslipidemia, especially those at high risk of cardiovascular events. It helps in lowering LDL cholesterol levels and elevating HDL cholesterol levels.
BENEFITS OF Evaprin 40mg Injection
The benefits of Evaprin 40mg Injection include:
- Improved lipid profiles: By inhibiting the CETP enzyme, Evaprin helps in enhancing HDL cholesterol levels and reducing LDL cholesterol levels, thus potentially reducing the risk of cardiovascular events.
- Cardiovascular risk reduction: By effectively managing dyslipidemia, Evaprin contributes to lowering the overall risk of cardiovascular diseases, such as heart attacks and strokes.
SIDE EFFECTS OF Evaprin 40mg Injection
Some potential side effects of Evaprin 40mg Injection may include:
- Gastrointestinal disturbances: Nausea, vomiting, diarrhea, or abdominal discomfort may occur.
- Headache: Some individuals may experience headaches as a side effect of Evaprin.
- Muscle pain: In rare cases, muscle pain or weakness may occur.
- Liver function abnormalities: There may be changes in liver enzyme levels, which should be monitored during treatment.
- Allergic reactions: Allergic reactions such as rash, itching, or swelling may occur in some individuals.
It’s important to consult a healthcare professional for a comprehensive understanding of the risks and benefits associated with Evaprin 40mg Injection and to report any adverse effects experienced during its use.
References
- Rovi Biotech Limited, Electronic Medicines Compendium (EMC), [Revised on Nov 2018], [Accessed on 27th May 2023], https://www.medicines.org.uk/emc/files/pil.9330.pdf
- Sanofi, [Revised on Apr 2022] [Accessed on 27th May 2023], https://products.sanofi.us/lovenox/lovenox.pdf
- Clexane® syringes 100mg/ml solution for Injection – HPRA. [Revised on May 2022], [Accessed on 27th May 2023], https://www.hpra.ie/img/uploaded/swedocuments/7900ad74-3eb7-41a2-be4c-3b757cb841ec.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Drugs Affecting Coagulation, Bleeding and Thrombosis, 8th Edition, 2019, 659-681.
Disclaimer
Singhla Medicos’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.
Reviews
There are no reviews yet.